Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

HFE genotype and transferrin saturation in the United States.

Cogswell ME, Gallagher ML, Steinberg KK, Caudill PhD SP, Looker AC, Bowman BA, Gunter EW, Franks AL, Satten GA, Khoury MJ, Grummer-Strawn LM.

Genet Med. 2003 Jul-Aug;5(4):304-10.

PMID:
12865759
2.

Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.

Thorstensen K, Kvitland MA, Irgens WØ, Hveem K, Asberg A.

Scand J Clin Lab Invest. 2010 Apr;70(2):92-7. doi: 10.3109/00365510903527838.

PMID:
20073670
3.
4.

Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.

Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, Garozzo G, Lancieri M, Rinaldi S, Testa D, Sampietro M, Tavazzi D, Delbini P, Fargion S, Fiorelli G.

Hematol J. 2003;4(6):436-40.

PMID:
14671617
5.

Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey.

Simsek H, Sumer H, Yilmaz E, Balaban YH, Ozcebe O, Hascelik G, Buyukask Y, Tatar G.

J Clin Gastroenterol. 2004 Sep;38(8):671-5.

PMID:
15319650
6.

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, Grummer-Strawn LM, Sampson EJ, Khoury MJ, Gallagher ML.

JAMA. 2001 May 2;285(17):2216-22.

PMID:
11325323
7.

Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.

Cassanelli S, Pignatti E, Montosi G, Garuti C, Mariano M, Campioli D, Carbonieri A, Baldini E, Pietrangelo A.

J Hepatol. 2001 Apr;34(4):523-8.

PMID:
11394651
8.

Population screening for hemochromatosis: a study in 5370 Spanish blood donors.

Sánchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R.

J Hepatol. 2003 Jun;38(6):745-50.

PMID:
12763366
9.

HFE gene mutations an Apulian population: allele frequencies.

Pietrapertosa A, Vitucci A, Campanale D, Palma A, Renni R, Delios G, Tannoia N.

Eur J Epidemiol. 2003;18(7):685-9.

PMID:
12952143
10.

[Molecular genetic diagnostics and screening of hereditary hemochromatosis].

Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.

Vnitr Lek. 2006 Jun;52(6):602-8. Slovak.

PMID:
16871764
11.

Frequencies of C282Y and H63D mutations and transferrin saturation indices in the Korean population.

Choi SJ, Min WK, Chun S, Park H, Kim JW, Park CJ, Chi HS.

Clin Chem Lab Med. 2002 Jul;40(7):689-92.

PMID:
12241015
12.

Screening for iron overload in the Turkish population.

Barut G, Balci H, Bozdayi M, Hatemi I, Ozcelik D, Senturk H.

Dig Dis. 2003;21(3):279-85.

PMID:
14571105
13.

Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.

Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL.

Blood Cells Mol Dis. 2002 Jul-Aug;29(1):41-7.

PMID:
12482402
14.

Contribution of different HFE genotypes to iron overload disease: a pooled analysis.

Burke W, Imperatore G, McDonnell SM, Baron RC, Khoury MJ.

Genet Med. 2000 Sep-Oct;2(5):271-7. Review.

PMID:
11399207
15.

Hemochromatosis and iron-overload screening in a racially diverse population.

Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.

N Engl J Med. 2005 Apr 28;352(17):1769-78.

16.

HFE mutations, iron deficiency and overload in 10,500 blood donors.

Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M.

Br J Haematol. 2001 Aug;114(2):474-84.

PMID:
11529872
17.

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D.

J Hepatol. 2003 Mar;38(3):335-42.

PMID:
12586300
18.

Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.

Moodie SJ, Ang L, Stenner JM, Finlayson C, Khotari A, Levin GE, Maxwell JD.

Eur J Gastroenterol Hepatol. 2002 Mar;14(3):223-9.

PMID:
11953685
19.

Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center.

Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E.

Am J Med. 2002 Oct 15;113(6):472-9.

PMID:
12427496
20.

Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods.

Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H.

Eur J Haematol. 2003 Dec;71(6):403-7.

PMID:
14703688

Supplemental Content

Support Center